fbpx

Författare: johan@emergers.se

GRANGEX: Upwards revision of reserves accompanied by strong macro backdrop

Analys, Research

GRÄNGESBERG EXPLORATION The ongoing preparations for the DFS of Dannemora has now yielded its second upwards revision, a 16% increase in...

Read More

NANEXA: New project NEX-22 to add significant daily benefits for 50m patient market

Analys, Research

Nanexa’s next proprietary development project, NEX-22, is a long-acting formulation of liraglutide for treatment of type 2 diabetes...

Read More

SIMRIS ALG: Cyano deal jumpstarts venture into Biopharma | See interview with CEO Julian Read

Analys

With the successful completion of the acquisition of Berlin-based Cyano Biotech GmbH, Simris Alg is now set to accelerate their entry into...

Read More

BONZUN: Set to refuel to latch on to global DTx trend

Analys

The Q2’22 report showed some continued progress for Bonzun’s stress management service, Bonzun Evolve, with 450 new licenses from KTH...

Read More

QLUCORE: CE headwind overshadows structural growth story

Analys, Research

While the business side of Qlucore is moving steady forward, with 67% growth, two new Qlucore Insight license deals and an expansion of the...

Read More

KEBNI: Strong momentum with near-term triggers to crystalise further upside potential

Analys

Besides completing a capital raise in these challenging market conditions, KebNi enjoys strong business momentum with new antenna orders...

Read More

DLABORATORY: Welcome boost from booming attention on power grid stability

Analys

The rise of network stability and electricity security on the public agenda has finally started to translate into a material rise in...

Read More

SIMRIS ALG: Accelerating entry into high-value BioPharma with acquisition of Cyano Biotech

Analys

In line with their strategic plan to move into the highest margin application areas, Simris Alg announced an LOI to acquire Cyano Biotech...

Read More

GRANGEX: Progress and project improvement against prolonged favorable macro backdrop

Analys, Research

As a result of the ongoing preparations of the DFS for Dannemora, GRANGEX now reports an upwards revision of the known and indicated...

Read More

SIMRIS ALG: Targeting biopharma to exploit highest value verticals in the microalgae and cyanobacteria space

Analys

With the new CEO in place, Simris has now set course to pursue the most high value application area for microalgae, the biopharma sector in...

Read More

Be first to read new research on growth stocks